Pharma Dynamics (Proprietary) Limited v Bayer Pharma AG and Another (468/2013)
Pharma Dynamics (Proprietary) Limited v Bayer Pharma AG and Another (468/2013) [2014] ZASCA 123; [2014] 4 All SA 302 (SCA); 2014 BIP 69 (SCA) (19 September 2014)
The SCA held that Ruby infringed Bayer’s patent for drospirenone/ethinylestradiol, and rejected Pharma Dynamics’ attacks based on obviousness and divisional validity.
- Patent Infringement
- Inventive Step
- Divisional Patent
- Novelty
- Pharmaceutical Patents
- Patent-infringement